Lifecore Biomedical Inc. Appoints KPMG as New Auditor Amid Internal Control Weakness Concerns

Reuters
Aug 19
<a href="https://laohu8.com/S/LFCR">Lifecore Biomedical</a> Inc. Appoints KPMG as New Auditor Amid Internal Control Weakness Concerns

Lifecore Biomedical Inc. has announced a change in its independent registered public accounting firm. The company's Audit Committee has appointed KPMG LLP as the new independent auditor for the transition period beginning May 26, 2025, and ending December 31, 2025. This decision follows the conclusion of a review and evaluation process. The company had previously identified weaknesses in its internal control over financial reporting and discussed these with its former auditor, BDO. However, there were no disagreements or reportable events between Lifecore and BDO during the fiscal years ended May 26, 2024, and May 25, 2025. KPMG was not consulted on any accounting principles or specific transactions during this time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lifecore Biomedical Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001005286-25-000118), on August 18, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10